Evidence-based two-and-seven criteria according to tumor number and size best help to predict survival of patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization

被引：0
|
作者：
Xia, D. [1 ]
Bai, W. [1 ]
Huang, M. [2 ]
Sun, J. [3 ,4 ]
Wang, E. [1 ]
Li, H. [5 ]
Li, J. [6 ,17 ]
Zhao, H. [7 ]
Pan, X. [8 ]
Chen, S. [9 ]
Gong, W. [10 ]
Zhu, X. [11 ]
Shao, G. [12 ]
Mu, W. [13 ]
Chen, Z. [14 ]
Wu, J. [15 ]
Liu, J. [16 ]
Li, J. [6 ,17 ]
Song, J. [18 ]
Zhang, C. [19 ]
Shi, H. [20 ]
Li, Z. [21 ]
Yang, S. [22 ]
Wang, W. [1 ,23 ]
Zheng, Y. [24 ]
Xu, J. [25 ]
Wang, W. [1 ,23 ]
Yuan, J. [1 ]
Li, X. [1 ]
Niu, J. [1 ]
Yin, Z. [1 ]
Fan, D. [1 ,26 ]
Xia, J. [27 ]
Han, G. [1 ]
机构：
[1] Forth Mil Med Univ, Xijing Hosp Digest Dis, Dept Liver Dis & Digest Intervent Radiol, Xian, Peoples R China
[2] Kunming Univ, Tumor Hosp Yunnan Prov, Affiliated Hosp 3, Dept Minimally Invas Int Therapy, Kunming, Peoples R China
[3] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hepatobiliary, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Pancreat Intervent Ctr, Hangzhou, Zhejiang, Peoples R China
[5] Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, Dept Intervent Radiol, Zhengzhou, Peoples R China
[6] Third Mil Med Univ, Xinqiao Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China
[7] Nantong Univ, Affiliated Hosp, Dept Intervent Radiol, Nantong, Peoples R China
[8] Peoples Liberat Army, Hosp 180, Clin Liver Dis Res Ctr, Quanzhou, Peoples R China
[9] Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Prov Canc Hosp, Dept Intervent Radiol, Nanjing, Jiangsu, Peoples R China
[10] Forth Mil Med Univ, Dept Intervent Radiol, Tangdu Hosp, Xian, Peoples R China
[11] Soochow Univ, Dept Intervent Radiol, Affiliated Hosp 1, Suzhou, Peoples R China
[12] Zhejiang Prov Tumor Hosp, Dept Intervent Radiol, Hangzhou, Zhejiang, Peoples R China
[13] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China
[14] Fujian Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Fuzhou, Peoples R China
[15] Nanchang Univ, Dept Oncol, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China
[16] Hunan Prov Peoples Hosp, Dept Intervent Radiol & Vasc Surg, Changsha, Hunan, Peoples R China
[17] Sun Yat Sen Univ, Dept Intervent Radiol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China
[18] Shandong Prov Tumor Hosp, Dept Intervent Therapy, Jinan, Peoples R China
[19] Shandong Univ, Shandong Prov Hosp, Dept Gastroenterol & Hepatol, Jinan, Peoples R China
[20] Nanjing Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[21] Qingdao Univ, Affiliated Hosp, Intervent Med Ctr, Qingdao, Peoples R China
[22] Xinjiang Med Univ, Dept Intervent Radiol, Affiliated Tumor Hosp, Urumqi, Peoples R China
[23] Lanzhou Univ, Affiliated Hosp 1, Dept Intervent Med, Lanzhou, Peoples R China
[24] Yantai Yuhuangding Hosp, Dept Intervent Radiol, Yantai, Peoples R China
[25] Nanjing Mil Command, Nanjing Gen Hosp, Dept Med Imaging, Nanjing, Jiangsu, Peoples R China
[26] Fourth Mil Med Univ, Xijing Hosp Digest Dis, State Key Lab Canc Biol, Xian, Peoples R China
[27] Forth Mil Med Univ, Dept Hlth Stat, Xian, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(17)30292-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PS-020
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 40 条
  • [1] New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization
    Kim, Jin Hyoung
    Shim, Ju Hyun
    Lee, Han Chu
    Sung, Kyu-Bo
    Ko, Heung-Kyu
    Ko, Gi-young
    Gwon, Dong Il
    Kim, Jong Woo
    Lim, Yung-Suk
    Park, Seong Ho
    LIVER INTERNATIONAL, 2017, 37 (12) : 1861 - 1868
  • [2] A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Motoyama, Tenyu
    Suzuki, Eiichiro
    Tawada, Akinobu
    Azemoto, Ryosaku
    Shinozaki, Masami
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    PLOS ONE, 2015, 10 (04):
  • [3] A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation
    Jia-yan Ni
    Zhu-ting Fang
    Hong-liang Sun
    Chao An
    Zhi-mei Huang
    Tian-qi Zhang
    Xiong-ying Jiang
    Yao-ting Chen
    Lin-feng Xu
    Jin-hua Huang
    European Radiology, 2020, 30 : 2377 - 2390
  • [4] A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation
    Ni, Jia-yan
    Fang, Zhu-ting
    Sun, Hong-liang
    An, Chao
    Huang, Zhi-mei
    Zhang, Tian-qi
    Jiang, Xiong-ying
    Chen, Yao-ting
    Xu, Lin-feng
    Huang, Jin-hua
    EUROPEAN RADIOLOGY, 2020, 30 (04) : 2377 - 2390
  • [5] THE COMPARISON BETWEEN OVERALL SURVIVAL OF TRANSARTERIAL CHEMOEMBOLIZATION AND BEST SUPPORTIVE CARE IN INTERMEDIATE-STAGE HEPATOCELLULAR CARCINOMA
    Akarapatima, Keerati
    Chang, Arunchai
    Prateepchaiboon, Tanaporn
    Pungpipattrakul, Nuttanit
    Songjamrat, Apiradee
    Pakdeejit, Songklod
    Rattanasupar, Attapon
    GUT, 2021, 70 : A73 - A74
  • [6] Post progression survival in patients with intermediate-stage hepatocellular carcinoma after receiving transarterial chemoembolization
    Shima, Yukiko
    Ogasawara, Sadahisa
    Ooka, Yoshihiko
    Kobayashi, Kazufumi
    Maruta, Susumu
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Maeda, Takahiro
    Kusakabe, Yuko
    Kiyono, Soichiro
    Nakamura, Masato
    Saito, Tomoko
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Chiba, Tetsuhiro
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Naoya
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E75 - E75
  • [7] Subgrouping of intermediate-stage (BCLC stage B) hepatocellular carcinoma based on tumor number and size and Child–Pugh grade correlated with prognosis after transarterial chemoembolization
    Koichiro Yamakado
    Shiro Miyayama
    Shozo Hirota
    Kimiyoshi Mizunuma
    Kenji Nakamura
    Yoshitaka Inaba
    Hiroaki Maeda
    Kunihiro Matsuo
    Norifumi Nishida
    Takeshi Aramaki
    Hiroshi Anai
    Shinichi Koura
    Shigeo Oikawa
    Ken Watanabe
    Taku Yasumoto
    Kinya Furuichi
    Masato Yamaguchi
    Japanese Journal of Radiology, 2014, 32 : 260 - 265
  • [8] Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma
    Ferreira-Silva, Joel
    Costa-Moreira, Pedro
    Cardoso, Helder
    Liberal, Rodrigo
    Pereira, Pedro
    Macedo, Guilherme
    GE PORTUGUESE JOURNAL OF GASTROENTEROLOGY, 2023, 30 (01) : 29 - 37
  • [9] Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria
    Hung, Ya-Wen
    Lee, I-Cheng
    Chi, Chen-Ta
    Lee, Rheun-Chuan
    Liu, Chien-An
    Chiu, Nai-Chi
    Hwang, Hsuen-En
    Chao, Yee
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    LIVER CANCER, 2021, 10 (06) : 629 - 640
  • [10] Subgrouping of intermediate-stage (BCLC stage B) hepatocellular carcinoma based on tumor number and size and Child-Pugh grade correlated with prognosis after transarterial chemoembolization
    Yamakado, Koichiro
    Miyayama, Shiro
    Hirota, Shozo
    Mizunuma, Kimiyoshi
    Nakamura, Kenji
    Inaba, Yoshitaka
    Maeda, Hiroaki
    Matsuo, Kunihiro
    Nishida, Norifumi
    Aramaki, Takeshi
    Anai, Hiroshi
    Koura, Shinichi
    Oikawa, Shigeo
    Watanabe, Ken
    Yasumoto, Taku
    Furuichi, Kinya
    Yamaguchi, Masato
    JAPANESE JOURNAL OF RADIOLOGY, 2014, 32 (05) : 260 - 265
1234